NC
IMGN

NewSquare Capital’s Immunogen Inc IMGN Stock Holding History

NewSquare Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-354
Closed -$3K – 411
2016
Q1 		$3K Buy
354
+306
+638% +$2.59K ﹤0.01% 375
2015
Q4 		$1K Hold
48
– – ﹤0.01% 340
2015
Q3 		$0 Hold
48
– – ﹤0.01% 361
2015
Q2 		$1K Hold
48
– – ﹤0.01% 344
2015
Q1 		$0 Hold
48
– – ﹤0.01% 345
2014
Q4 		$0 Hold
48
– – ﹤0.01% 346
2014
Q3 		$1K Hold
48
– – ﹤0.01% 322
2014
Q2 		$1K Buy
+48
New +$602 ﹤0.01% 279

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NewSquare Capital's IMGN Position: Q2 2016 in Review

NewSquare Capital sold out of Immunogen Inc (IMGN) in Q2 2016, closing a stake of 354 shares — an estimated $3K sold.

NewSquare Capital first reported a position in IMGN in Q2 2014 and held it in 8 quarters. The position peaked at $3K in Q1 2016. 158 funds tracked by Wall St. Rank hold IMGN as of Q2 2016.

  • NewSquare Capital reported no remaining Immunogen Inc position as of Q2 2016 after selling out during the quarter.
  • NewSquare Capital sold 354 Immunogen Inc shares in Q2 2016, an estimated $3K.
  • NewSquare Capital first reported a position in Immunogen Inc in Q2 2014 and held it in 8 quarters.
  • NewSquare Capital's Immunogen Inc position peaked at $3K in Q1 2016.
  • 158 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2016.

Based on NewSquare Capital's 13F filing for Q2 2016, filed 25 Jul 2016.